The patient’s BMB was negative for lymphoma or other pathology, and a diagnosis of axial metastasis secondary to primary prostate cancer was presumed. Further, his hypercoagulable profile was heterozygous for a prothrombin G20210A gene mutation and elevated homocysteine level (Table 1) [4,8]. Here, F2 is linked to prostate carcinoma.